Trial Profile
The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Plafond (Pilon) Fractures: A Pilot Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Apr 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle injury; Muscle spasticity
- Focus Therapeutic Use
- 10 Feb 2016 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
- 02 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 10 Mar 2014 New trial record